Squarepoint Ops LLC Ac Immune Sa Transaction History

Squarepoint Ops LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.85 - $3.4 $20,416 - $37,522	11,036 New	11,036 $32,000
Q2 2021 Aug 16, 2021	SELL	$6.04 - $8.37 $114,307 - $158,402	-18,925 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$5.32 - $8.96 $161,211 - $271,514	-30,303 Reduced 61.56%	18,925 $144,000
Q4 2020 Feb 16, 2021	BUY	$4.47 - $5.58 $220,049 - $274,692	49,228 New	49,228 $255,000
Q2 2020 Aug 14, 2020	SELL	$6.57 - $8.3 $91,060 - $115,038	-13,860 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$4.24 - $9.89 $58,766 - $137,075	13,860 New	13,860 $96,000
Q1 2019 May 15, 2019	SELL	$3.65 - $11.68 $46,720 - $149,504	-12,800 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$7.35 - $11.7 $94,080 - $149,760	12,800 New	12,800 $121,000

28.2M

150K

12.4K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $296M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.